DOI QR코드

DOI QR Code

Radixin Knockdown by RNA Interference Suppresses Human Glioblastoma Cell Growth in Vitro and in Vivo

  • Qin, Jun-Jie (Department of Neuropathology, Beijing Neurosurgical Institute) ;
  • Wang, Jun-Mei (Department of Neuropathology, Beijing Neurosurgical Institute) ;
  • Du, Jiang (Department of Neuropathology, Beijing Neurosurgical Institute) ;
  • Zeng, Chun (Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, China National Clinical Research Center for Neurological Diseases, Center of Brain Tumor, Beijing Institute for Brain Disorders, Beijing Key Laboratory of Brain Tumors) ;
  • Han, Wu (Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, China National Clinical Research Center for Neurological Diseases, Center of Brain Tumor, Beijing Institute for Brain Disorders, Beijing Key Laboratory of Brain Tumors) ;
  • Li, Zhi-Dong (Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, China National Clinical Research Center for Neurological Diseases, Center of Brain Tumor, Beijing Institute for Brain Disorders, Beijing Key Laboratory of Brain Tumors) ;
  • Xie, Jian (Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, China National Clinical Research Center for Neurological Diseases, Center of Brain Tumor, Beijing Institute for Brain Disorders, Beijing Key Laboratory of Brain Tumors) ;
  • Li, Gui-Lin (Department of Neuropathology, Beijing Neurosurgical Institute)
  • 발행 : 2014.12.18

초록

Radixin, a member of the ERM (ezrin-radixin-moesin) family, plays important roles in cell motility, invasion and tumor progression. It is expressed in a variety of normal and neoplastic cells, including many types of epithelial and lymphoid examples. However, its function in glioblastomas remains elusive. Thus, in this study, radixin gene expression was first examined in the glioblastoma cells, then suppressed with a lentivirus-mediated short-hairpin RNA (shRNA) method.We found that there were high levels of radixin expression in glioblastoma U251cells. Radixin shRNA caused down-regulation of radixin gene expression and when radixin-silenced cells were implanted into nude mice, tumor growth was significantly inhibited as compared to blank control cells or nonsense shRNA cells. In addition, microvessel density in the tumors was significantly reduced. Thrombospondin-1 (TSP-1) and E-cadherin were up-regulated in radixin- suppressed glioblastoma U251 cells. In contrast, MMP9 was down-regulated. Taken together, our findings suggest that radixin is involved in GBM cell migration and invasion, and implicate TSP-1, E-cadherin and MMP9 as metastasis-inducing factors.

키워드

참고문헌

  1. Albini A, Iwamoto Y, Kleinman HK, et al (1987). A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res, 47, 3239-45.
  2. Berx G, Staes K, van Henqel J, et al (1995). Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1). Genomics, 26, 281-9. https://doi.org/10.1016/0888-7543(95)80212-5
  3. Bretscher A, Edwards K, Fehon RG (2002). ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol, 3, 586-99.
  4. Butler WB, Berlinski PJ, Hillman RM, et al (1986). Relation of in vitro properties to tumorigenicity for a series of sublines of the human breast cancer cell line MCF-7. Cancer Res, 46, 6339-48.
  5. Castle VP, Dixit VM, Polverini PJ (1997). Thrombospondin-1 suppresses tumorigenesis and angiogenesis in serum- and anchorage-independent NIH 3T3 cells. Lab Invest, 77, 51-61.
  6. Chen J, Xie F, Zhang L, et al (2010). iASPP is over-expressed in human non-small cell lung cancer and regulates the proliferation of lung cancer cells through a p53 associated pathway. BMC Cancer, 10, 694. https://doi.org/10.1186/1471-2407-10-694
  7. Chen SD, Song MM, Zhong ZQ, et al (2012). Knockdown of radixin by RNA interference suppresses the growth of human pancreatic cancer cells in vitro and in vivo. Asian Pac J Cancer Prev, 13, 753-9. https://doi.org/10.7314/APJCP.2012.13.3.753
  8. Cheng CL, Johnson SP, Keir ST, et al (2005). Poly (ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair-deficient malignant glioma xenograft. Mol Cancer Ther, 4, 1364-8. https://doi.org/10.1158/1535-7163.MCT-05-0128
  9. Curto M, McClatchey AI (2004). Ezrin a metastatic detERMinant? Cancer Cel, 5,113-4. https://doi.org/10.1016/S1535-6108(04)00031-5
  10. Darakhshan S, Bidmeshkipour A, Khazaei M, et al (2013). Synergistic effects of tamoxifen and tranilast on VEGF and MMP-9 Regulation in cultured human breast cancer cells. Asian Pac J Cancer Prev, 14, 6869-74. https://doi.org/10.7314/APJCP.2013.14.11.6869
  11. Forsyth PA, Laing TD, Gibson AW, et al (1998). High levels of gelatinase-B and active gelatinase-A in metastatic glioblastoma. J Neurooncol, 36, 21-9. https://doi.org/10.1023/A:1005879027267
  12. Forsyth PA, Wong H, Laing TD, et al (1999). Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br J Cancer, 79, 1828-35. https://doi.org/10.1038/sj.bjc.6990291
  13. Frisch SM, Francis H (1994). Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol, 124, 619-26. https://doi.org/10.1083/jcb.124.4.619
  14. Gautreau A, Louvard D, Arpin M (2002). ERM proteins and NF2 tumor suppressor: the Yin and Yang of cortical actin organization and cell growth signaling. Curr Opin Cell Biol, 14, 104-9. https://doi.org/10.1016/S0955-0674(01)00300-3
  15. Geiger KD, Stoldt P, Schlote W, et al (2000). Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas. Am J Pathol, 157, 1785-93. https://doi.org/10.1016/S0002-9440(10)64816-X
  16. Guo H, Ma Y, Zhang B, et al (2009). Pivotal advance: PKCzeta is required for migration of macrophages. J Leukoc Biol, 85, 911-8. https://doi.org/10.1189/jlb.0708429
  17. Hanahan D, Folkman J (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86, 353-64. https://doi.org/10.1016/S0092-8674(00)80108-7
  18. Hoeflich KP, Ikura M (2004). Radixin: cytoskeletal adopter and signaling protein. Int J Biochem Cell Biol, 36, 2131-6. https://doi.org/10.1016/j.biocel.2003.11.018
  19. Hoeflich KP, Tsukita S, Hicks L, et al (2003). Insights into a single rod-like helix in activated radixin required for membranecytoskeletal cross-linking. Biochemistry, 42, 11634-41. https://doi.org/10.1021/bi0350497
  20. Hoffman S, Propp JM, McCarthy BJ (2006). Temporal trends in incidence of primary brain tumors in the United States, 1985- 1999. Neuro Oncol, 8, 27-37. https://doi.org/10.1215/S1522851705000323
  21. Jimenez B, Volpert OV, Crawford SE, et al (2000). Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med, 6, 41-8. https://doi.org/10.1038/71517
  22. Jin J, Cai L, Liu ZM, et al (2013). miRNA-218 Inhibits Osteosarcoma Cell Migration and Invasion by Down-regulating of TIAM1, MMP2 and MMP9. Asian Pac J Cancer Prev, 14, 3681-4. https://doi.org/10.7314/APJCP.2013.14.6.3681
  23. Khanna C, Wan X, Bose S, et al (2004). The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med, 10, 182-6. https://doi.org/10.1038/nm982
  24. Kidoikhammouan S, Seubwai W, Tantapotinan N, et al (2013). TNP-470, A methionine aminopeptidase-2 inhibitor, inhibits cell proliferation, migration and invasion of human cholangiocarcinoma Cells In Vitro. Asian Pac J Cancer Prev, 13, 155-60.
  25. Kikuchi S, Hata M, Fukumoto K, et al (2002). Radixin deficiency causes conjugated hyperbilirubinemia with loss of Mrp2 from bile canalicular membranes. Nat Gene, 31, 320-5. https://doi.org/10.1038/ng905
  26. Kjaergaard J, Wang LX, Kuriyama H, et al (2005). Active immunotherapy for advanced intracranial murine tumors by using dendritic cell-tumor cell fusion vaccines. J Neurosurg 103, 156-64. https://doi.org/10.3171/jns.2005.103.1.0156
  27. Lawler J, Miao WM, Duquette M, et al (2001). Thrombospondin-1 gene expression affects survival and tumor spectrum of p53- deficient mice. Am J Pathol, 159, 1949-56. https://doi.org/10.1016/S0002-9440(10)63042-8
  28. Liotta LA, Steeg PS, Stetler-Stevenson WG (1991). Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64, 327-36. https://doi.org/10.1016/0092-8674(91)90642-C
  29. McClatchey AI (2003). Merlin and ERM proteins: unappreciated roles in cancer development? Nat Rev Cancer, 3, 877-83. https://doi.org/10.1038/nrc1213
  30. Meng Y, Lu Z, Yu S, et al (2010). Ezrin promotes invasion and metastasis of pancreatic cancer cells. J Transl Med, 8, 61. https://doi.org/10.1186/1479-5876-8-61
  31. Moon Y, Bottone FGJr, McEntee MF, et al (2005). Suppression of tumor cell invasion by cyclooxygenase inhibitors is mediated by thrombospondin-1 via the early growth response gene Egr-1. Mol Cancer Ther, 4, 1551-8. https://doi.org/10.1158/1535-7163.MCT-05-0213
  32. Nakada M, Nakada S, Demuth T, et al (2007). Molecular targets of glioma invasion. Cell Mol Life Sci, 64, 458-78. https://doi.org/10.1007/s00018-007-6342-5
  33. Ng SS, Cheung YT, An XM, et al (2007). Cell cycle-related kinase: a novel candidate oncogene in human glioblastoma. J Natl Cancer Inst, 99, 936-48. https://doi.org/10.1093/jnci/djm011
  34. Ou-Yang M, Liu H R, Zhang Y, et al (2011). ERM stable knockdown by siRNA reduced in vitro migration and invasion of human SGC-7901 cells. Biochimie, 93, 954-61. https://doi.org/10.1016/j.biochi.2011.01.017
  35. Paglini G, Kunda P, Quiroga S, et al. (1998). Suppression of radixin and moesin alters growth cone morphology, motility, and process formation in primary cultured neurons. J Cell Biol, 143, 443-55. https://doi.org/10.1083/jcb.143.2.443
  36. Persson A, Lindwall C, Curtis MA, et al (2010). Expression of ezrin radixin moesin proteins in the adult subventricular zone and the rostral migratory stream. Neuroscience, 167, 312-22. https://doi.org/10.1016/j.neuroscience.2010.01.035
  37. Ramoni C, Luciani F, Spadaro F, et al (2002). Differential expression and distribution of ezrin, radixin and moesin in human natural killer cells. Eur J Immunol, 32, 3059-65. https://doi.org/10.1002/1521-4141(200211)32:11<3059::AID-IMMU3059>3.0.CO;2-3
  38. Revillion F, Lhotellier V, Hornez L, et al (2008). Real-time reversetranscription PCR to quantify a panel of 19 genes in breast cancer: relationships with sentinel lymph node invasion. Int J Biol Markers, 23, 10-7.
  39. Schneider T, Mawrin C, Scherlach C, et al (2010). Gliomas in adults. Dtsch Arztebl Int, 107, 799-807.
  40. Singh S, Sadanandam A, Varney ML, et al (2010). Small interfering RNA-mediated CXCR1 or CXCR2 knock-down inhibits melanoma tumor growth and invasion. Int J Cancer, 126, 328-36. https://doi.org/10.1002/ijc.24714
  41. Stemmler MP (2008). Cadherins in development and cancer. Mol Biosyst, 4, 835-50. https://doi.org/10.1039/b719215k
  42. Stupp R, Hegi M E, van den Bent MJ, et al. (2006). Changing paradigms-an update on the multidisciplinary management of malignant glioma. Oncologist, 11, 165-80. https://doi.org/10.1634/theoncologist.11-2-165
  43. Suda J, Zhu L, Karvar S (2011). Phosphorylation of radixin regulates cell polarity and Mrp-2 distribution in hepatocytes. Am J Physiol Cell Physiol, 300, 416-24. https://doi.org/10.1152/ajpcell.00467.2010
  44. Sun XJ, Liu H, Zhang P, et al (2013). miR-10b promotes migration and invasion in nasopharyngeal carcinoma cells. Asian Pac J Cancer Prev, 14, 5533-7. https://doi.org/10.7314/APJCP.2013.14.9.5533
  45. Takeichi M (1993). Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol, 5, 806-11. https://doi.org/10.1016/0955-0674(93)90029-P
  46. Tsukita S, Yonemura S (1999). Cortical actin organization: lessons from ERM (ezrin/radixin/moesin) proteins. J Biol Chem, 274, 34507-10. https://doi.org/10.1074/jbc.274.49.34507
  47. Turunen O, Wahlstrom T, Vaheri A (1994). Ezrin has a COOHterminal actin-binding site that is conserved in the ezrin protein family. J Cell Biol, 126, 1445-53. https://doi.org/10.1083/jcb.126.6.1445
  48. Tynninen O, Carpen O, Jaaskelainen J, et al (2004). Ezrin expression in tissue microarray of primary and recurrent gliomas. Neuropathol Appl Neurobiol, 30, 472-7. https://doi.org/10.1111/j.1365-2990.2004.00562.x
  49. Uhm JH, Dooley NP, Villemure JG, et al (1997). Mechanisms of glioma invasion: role of matrix-metalloproteinases. Can J Neurol Sci, 24, 3-15.
  50. van Roy F and Berx G (2008). The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci, 65, 3756-88. https://doi.org/10.1007/s00018-008-8281-1
  51. Wen PY, Yung WK, Lamborn KR, et al (2006). Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08. Clin Cancer Res, 12, 4899-907. https://doi.org/10.1158/1078-0432.CCR-06-0773
  52. Xia H, Qi Y, Ng SS, et al (2009). microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs. Brain Res, 1269, 158-65. https://doi.org/10.1016/j.brainres.2009.02.037
  53. Yahayo W, Supabpho A, Supabphol R (2013). Suppression of human fibrosarcoma cell metastasis by Phyllanthus emblica extract in Vitro. Asian Pac J Cancer Prev, 14, 6863-7. https://doi.org/10.7314/APJCP.2013.14.11.6863

피인용 문헌

  1. Global long non-coding RNA expression in the rostral anterior cingulate cortex of depressed suicides vol.8, pp.1, 2018, https://doi.org/10.1038/s41398-018-0267-7
  2. Proteomics and Visual Health Research: Proteome of the Human Sclera Using High-Resolution Mass Spectrometry vol.23, pp.2, 2019, https://doi.org/10.1089/omi.2018.0185